Maria Abbracchio
Maria Pia Abbracchio is an Italian pharmacologist and neuroscientist known for her significant contributions to the field of pharmacology. She is particularly recognized for her research on purinergic signalling, a type of cell signalling that involves purine nucleotides and nucleosides.
Early Life and Education[edit | edit source]
Abbracchio was born in Milan, Italy. She completed her undergraduate studies in Pharmacy at the University of Milan, where she also earned her PhD in Pharmacology.
Career[edit | edit source]
Following her PhD, Abbracchio continued her research at the University of Milan, focusing on the pharmacology of purinergic receptors. Her work has significantly contributed to the understanding of the role of these receptors in health and disease.
In addition to her research, Abbracchio has held several academic positions. She has served as a professor of pharmacology at the University of Milan and has been a visiting professor at several international institutions.
Research[edit | edit source]
Abbracchio's research primarily focuses on purinergic signalling, a type of cell signalling that involves purine nucleotides and nucleosides. Her work has led to the identification of several new P2Y receptor subtypes and has provided insights into their roles in various physiological and pathological conditions.
Abbracchio's research has also explored the therapeutic potential of targeting purinergic signalling pathways in various diseases, including neurodegenerative diseases and cancer.
Awards and Honors[edit | edit source]
Abbracchio has received numerous awards and honors for her contributions to pharmacology. These include the British Pharmacological Society's Gaddum Memorial Award and the Italian Society of Pharmacology's Ettore Majorana Prize.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
